z-logo
open-access-imgOpen Access
Age‐related changes in mesenchymal stem cells derived from rhesus macaque bone marrow
Author(s) -
Yu Ji Min,
Wu Xiying,
Gimble Jeffrey M.,
Guan Xiaoyan,
Freitas Michael A.,
Bunnell Bruce A.
Publication year - 2011
Publication title -
aging cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.103
H-Index - 140
eISSN - 1474-9726
pISSN - 1474-9718
DOI - 10.1111/j.1474-9726.2010.00646.x
Subject(s) - biology , mesenchymal stem cell , stem cell , microbiology and biotechnology , microrna , heat shock , immunology , heat shock protein , genetics , gene
Summary The regeneration potential of mesenchymal stem cells (MSCs) diminishes with advanced age and this diminished potential is associated with changes in cellular functions. This study compared MSCs isolated from the bone marrow of rhesus monkeys (rBMSCs) in three age groups: young (< 5 years), middle (8–10 years), and old (> 12 years). The effects of aging on stem cell properties and indicators of stem cell fitness such as proliferation, differentiation, circadian rhythms, stress response proteins, miRNA expression, and global histone modifications in rBMSCs were analyzed. rBMSCs demonstrated decreased capacities for proliferation and differentiation as a function of age. The production of heat shock protein 70 (HSP70) and heat shock factor 1 (HSF1) were also reduced with increasing age. The level of a core circadian protein, Rev‐erb α , was significantly increased in rBMSCs from old animals. Furthermore, analysis of miRNA expression profiles revealed an up‐regulation of mir‐766 and mir‐558 and a down‐regulation of mir‐let‐7f, mir‐125b, mir‐222, mir‐199‐3p, mir‐23a, and mir‐221 in old rBMSCs compare to young rBMSCs. However, there were no significant age‐related changes in the global histone modification profiles of the four histone core proteins: H2A, H2B, H3, and H4 on rBMSCs. These changes represent novel insights into the aging process and could have implications regarding the potential for autologous stem cells therapy in older patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here